Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Next-generation drug delivery systems for aspergillosis: Overcoming barriers in antifungal therapy
Biomedicine and Pharmacotherapy
August 2026
Martins Y.A.
Open Access
Development and characterization of Trojan microspheres based dry powder inhalers for delivery of antitubercular agent
Drying Technology
2026
Baviskar P.
Nanostructured lipid carriers-loaded dry powder inhaler for pulmonary delivery of amphotericin B in treatment of allergic bronchopulmonary aspergillosis
International Journal of Pharmaceutics
15 September 2025
Florensia Dana Carla B.
Surface-Decoration of Solid Lipid Nanoparticles (SLNs) Using 7D12 Nanobody for Targeted Delivery of 5-Fluorouracil to Colorectal cancer Cells: Preparation, Statistical Optimization and Cytotoxicity Studies
Journal of Pharmaceutical Innovation
August 2025
Salimi Z.
Inhalable Nanotechnology-Based Drug Delivery Systems for the Treatment of Inflammatory Lung Diseases
Pharmaceutics
July 2025
Mahmoud D.E.
Open Access
Solid lipid nanoparticles for drug delivery
Lipid Based Nanocarriers for Drug Delivery
9 August 2024
Kaur H.
A Review on Micro and Nanoengineering in Powder-Based Pulmonary Drug Delivery
International Journal of Pharmaceutics
25 June 2024
Pasero L.
Open Access
Development, Statistical Optimization, and Characterization of Resveratrol-Containing Solid Lipid Nanoparticles (SLNs) and Determination of the Efficacy in Reducing Neurodegenerative Symptoms Related to Alzheimer’s Disease: In Vitro and In Vivo Study
Biomed Research International
2024
Khishvand M.A.
Open Access
Unroasted Green Coffee Extract-Loaded Solid Lipid Nanoparticles for Enhancing Intestinal Permeation
ACS Omega
13 June 2023
Moussa Y.A.
Open Access
Dry Powder Inhaler with the technical and practical obstacles, and forthcoming platform strategies
Journal of Controlled Release
March 2023
Gaikwad S.S.
Solid lipid nanoparticles as innovative strategies for the treatment and prophylaxis of infectious diseases
Infectious Diseases from Prevention to Control
1 March 2023
Laboccetta C.R.
Could the Lung Be a Gateway for Amphotericin B to Attack the Army of Fungi?
Pharmaceutics
December 2022
de Carvalho Patricio B.F.
Open Access
Advances in lipid-based pulmonary nanomedicine for the management of inflammatory lung disorders
Nanomedicine
May 2022
Kumar M.
Glioblastoma multiforme targeted delivery of docetaxel using bevacizumab-modified nanostructured lipid carriers impair in vitro cell growth and in vivo tumor progression
International Journal of Pharmaceutics
25 April 2022
Di Filippo L.D.
All Open Access, Green
Inhaled Antifungal Agents for Treatment and Prophylaxis of Bronchopulmonary Invasive Mold Infections
Pharmaceutics
March 2022
Brunet K.
Open Access
Anti-CD44 and EGFR Dual-Targeted Solid Lipid Nanoparticles for Delivery of Doxorubicin to Triple-Negative Breast Cancer Cell Line: Preparation, Statistical Optimization, and in Vitro Characterization
Biomed Research International
2022
Darabi F.
Open Access
Advances in therapeutic nanodrug delivery systems for infectious lung diseases: a review
Acta Materia Medica
2022
Sheng G.
Open Access
Nanoparticle-Based Drug Delivery System: The Magic Bullet for the Treatment of Chronic Pulmonary Diseases
Molecular Pharmaceutics
4 October 2021
Pramanik S.